hrp0086p1-p812 | Syndromes: Mechanisms and Management P1 | ESPE2016

Skeletal Disproportion in Girls with Turner Syndrome

McVey L , Fletcher A , Murtaza M , Donaldson MD , Wong SC , Mason A

Background: Turner Syndrome (TS) is associated with short stature and skeletal disproportion. The impact of treatment with recombinant human growth hormone (rhGH) and oestrogen therapy on body proportions is unclear.Objectives: To evaluate sitting height (SH) and leg length (LL) in TS before growth promoting therapies and at adult height.Method: Retrospective study of height (Ht), SH and LL standard deviation score (SDS) in TS. Bod...

hrp0094p2-318 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Thyroid status in children with Turner syndrome

Peskavaya Nadzeya , Solntsava Anzhalika , Akulevich Natallia ,

Objectives: To evaluate the prevalence and characteristics of thyroid diseases in children with Turner syndrome (TS).Methods: This is a retrospective study, analyzing clinical data from medical records of 167 patients with TS from 3 to 18 years, who were regularly followed-up in the University hospital (Minsk). Depending on the karyotype, 4 groups of patients were identified: the first group with karyotype 45,X (n</e...

hrp0086p2-p867 | Syndromes: Mechanisms and Management P2 | ESPE2016

Growth Hormone Treatment in a Child with Trisomy 21 and Turner Mosaicism

Lim Sharon

Background: Short stature occurs in Trisomy 21 but it is relatively slight during childhood. Turner syndrome would contribute significantly to short stature but the combined occurrence of both syndromes, even Turner mosaicism is unusual and could result in significant short stature.Case: SP was referred for a growth assessment at 2.5 years. Her parents were counselled about short stature occurring in both syndromes but were worried that her height was si...

hrp0094wg8.3 | ESPE Working Group on Turner Syndrome Symposium | ESPE2021

Blood Pressure in Turner Syndrome - a practical approach

Matthews Debbie ,

Females with Turner syndrome (TS) have a reduced life expectancy of about 13 years and a substantial excess mortality; about 50% of this is the result of cardiovascular pathology. Hypertension affects 20-60% of females with TS and is the single most modifiable risk factor for cardiovascular disease. However, hypertension in TS is both under-diagnosed and under-treated. The presentation details a practical approach to monitoring blood pressure and managing hypertension in TS. T...

hrp0089p3-p263 | Growth &amp; Syndromes P3 | ESPE2018

A Patient with Turner Syndrome (45X/46XX) and Congenital Adrenal Hyperplasia

Wang Yirou , Ding Yu , Chang Guoying , Chen Yao , Shen Yiping , Wang Xiumin , Wang Jian

An association between Turner syndrome (TS) and Congenital Adrenal Hyperplasia (CAH) due to 21-hydroxylase deficiency is rare. TS is caused by partial or complete loss of the second sexual chromosome which leads to genital system malformation and infertility. 21-hydroxylase deficiency is a well-known cause of disorder of sexual development in genotypic female neonates.The aim of our study is to report this patient and stress this rare possibility. A 8-month-old patient sufferi...

hrp0089p3-p223 | Growth &amp; Syndromes P3 | ESPE2018

Coeliac Disease in Turner Syndrome More Frequent Than Expected

Ouidad Baz , Mourad Semrouni , Samia Sakher , Zerguini Safia Mimouni

Abstract: The risk of developing coeliac disease (CD) is higher in Turner syndrome (TS) than the general population, and screening has been recommended in asymptomatic individuals known to have an increased risk of developing the disease. In light of this recommendation, the aim of the study was to assess prevalence of celiac disease in Turner syndrome.Patients and methods: Serological screening of coeliac disease were performed in 85 children and adoles...

hrp0089p3-p227 | Growth &amp; Syndromes P3 | ESPE2018

Auditing Presentation, Investigations and Management of Turner’s Syndrome

Gunasekara Buddhi , Premathilaka Dilusha , Hasheem Raihana , Kollurage Udeni , Suntharesan Janani , Jeyanthakumar Rasarathinum , Armugam Puvana , Atapattu Navoda

Background: Turner’s syndrome (TS) is the most common genetic disorder in females affecting approximately 1 in 2500 live female births as a result of partial or complete X chromosomal monosomy. TS mostly affect skeletal, cardiovascular, endocrine and reproductive systems. Girls with TS present with short stature and dysmorphic features such as webbed neck and delayed puberty. Age at diagnosis of children with TS is extremely important to start growth hormone at younger ag...

hrp0084p2-549 | Puberty | ESPE2015

Balance Control in Children and Adolescent Girls with Turner Syndrome

Peultier Laetitia , Gauchard Gerome , Leheup Bruno , Lebon-Labich Beatrice , Perrin Phlippe

Background: Turner syndrome (TS), affects approximately 1/2500 live female births. The clinical features range from a severe phenotypic character to reduction of final height and premature ovarian failure.Objective and hypotheses: Processing of sensory information from visual, vestibular and somatokinesthetic systems is required to organize an adequate motor response aiming at gaze and posture stabilization according to the expected task and to the envir...

hrp0097p2-7 | Growth and Syndromes | ESPE2023

Survey of the Prevalence of Balance Issues in Turner Syndrome

Duncan Nicola , Todd Stacey , Smyth Arlene , Mason Avril , Kubba Haytham

Background: Turner Syndrome (TS) is commonly complicated by otological problems, of which middle ear infections, conductive and sensorineural hearing losses are most frequent. Middle ear infection and hearing loss, isolated or in combination, have putative roles in balance disturbance and may be related to the increased fracture risk exhibited in TS in adulthood. Our aim was to both establish the prevalence of balance problems in TS during childhood and explor...

hrp0084wg6.1 | Turner Syndrome | ESPE2015

Incidental Prenatal Diagnosis of Turner Syndrome, Perspectives of Parents and Professionals

Pieters Jacqueline

In the light of technologic advances in prenatal testing, more genetic information about the fetus will become available, some of which may have uncertain clinical significance. In the light of all new genetic diagnosing technologies, professional guidance of patients to reliable, tailored, and accurate information is essential. In this presentation I analyze and discuss the various aspects of parental attitudes and dilemmas, as well as professional opinions about the benefits...